New Drug Applications

Sunovion Resubmits New Drug Application for Apomorphine Sublingual Film

7 years ago
by David Miller
954 Views
Written by David Miller

MARLBOROUGH, Mass.–(BUSINESS WIRE) November 22, 2019 –Sunovion Pharmaceuticals Inc. (Sunovion) today announced the resubmission of the New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for apomorphine sublingual film…Original Article

You may also like

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts
[mwai_chat window="true" fullscreen="true"]